Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 3Thoracic 1Sarcoma 1NET 1Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Central Nervous System Neoplasms 6Glioblastoma 4Brain Neoplasms 4Pancreatic Neoplasms 3Colonic Neoplasms 3Stomach Neoplasms 2Sarcoma 2Rhabdoid Tumor 2Prostatic Neoplasms 2Neuroblastoma 2Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Melanoma 2Medulloblastoma 2Lymphoma 2Gliosarcoma 2Gallbladder Neoplasms 2Colorectal Neoplasms 2Choroid Plexus Neoplasms 2Carcinoma, Hepatocellular 2Astrocytoma 2Vipoma 1Thyroid Neoplasms 1Somatostatinoma 1Retinoblastoma 1Rectal Neoplasms 1Pseudomyxoma Peritonei 1Pheochromocytoma 1Osteosarcoma 1

Interventions

tipifarnib 1pentetreotide 1Trastuzumab 1Oxaliplatin 1Leucovorin 1Floxuridine 1Fentanyl 190Y-octreotide, DOTA-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrinoma × Leucovorin × CNS × Clear all
NCT00005860 2011-04-26

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

National Cancer Institute (NCI)

Phase 1 Completed
CNSEndocrineGastrointestinalGynecologicSarcoma

Appendiceal Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Vipoma, Fallopian Tube Neoplasms, Gallbladder Neoplasms, Glucagonoma, Carcinoma, Hepatocellular, Insulinoma, Neoplasms, Neoplasms, Unknown Primary, Neuroblastoma, Pancreatic Neoplasms, Pheochromocytoma, Pseudomyxoma Peritonei, Somatostatinoma, Stomach Neoplasms, Gastrinoma, Carcinoma, Islet Cell, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡